Skip to content

The study of central network mechanism of treating perimenopausal syndrome with acupuncture based on fMRI

Randomized controlled study on the effectiveness of acupuncture treating perimenopausal syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14005000
Enrollment
Unknown
Registered
2014-06-30
Start date
2014-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

perimenopausal syndrome

Interventions

acupuncture group:Needle acupuncture points
sham-acupoint acupuncture group:Needle acupuncture points

Sponsors

Acupuncture and Tuina College of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 55 Years

Inclusion criteria

Inclusion criteria: The International Menopause Society 2011 and North American Menopause Society 2001 diagnostic standards were based: 1) Menstrual irregularities more than 3times, or menopause, but less than 12 months; 2) Related symptoms appears: Vasomotor instability, such as flush of the face, hyperhidrosis, or Neuropsychiatric symptoms, such as Insomnia, migraine, dysphoria, or Urogenital atrophy symptoms, such as Vaginal dryness, painful intercourse. There are individual differences in various combinations and severity of symptoms; 3) to exclude uterus or ovaries organic diseases through Ultrasound or imaging.Note: diagnosis can only be made after meeting three conditions all above. a) Meet the diagnostic criteria of perimenopausal syndrome,Right-handed, younger than 40, or older than 55; b) without taking estrogen, SSRIs, soy isoflavones, progesterone, vitamin E, or black cohosh 4 weeks before participate study or haven't taken part in other similar studies; c) Without any mental or neurological history and family history; d) without MRI contraindications, like Pacemaker, metal dentures or braces implanted; e) good physical condition during study, no cold, headache, cough, etc.; f) have signed the informed consent of patient.

Exclusion criteria

Exclusion criteria: a) unconscious or unable to cooperate with the inspection or with psychiatric symptoms; b) progressive cancer or other serious debilitating diseases; c) Combine with severe primary cardiovascular, cerebrovascular, kidney, blood and other vital organs and systems disease; d) With severe depression or anxiety (Moderate or severe anxiety or depression measured by SAS or SDS Scale); e) intended pregnancy or in pregnancy or lactation; f) have various diseases with severe pain (released only after bed rest or medication); g) with MRI contraindications, such as claustrophobia; h) traumatic brain injury; i) Both ovaries and Uterus are removed; j) Informed consent is not signed.

Design outcomes

Primary

MeasureTime frame
MRS;

Secondary

MeasureTime frame
MENQOL;PSQI;SAS;SDS;

Contacts

Public ContactLi Ying
1251615100@qq.com+86 13708095607

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026